TJ Dillashaw Accepts Two Year USADA Suspension
The United State Anti-Doping Agency (USADA) has now announced that Dillashaw has accepted a two year suspension after testing positive for a substance known as recombinant human erythropoietin (rHuEPO).
USADA issued the following press release on the matter:
April 9, 2019
USADA announced today that TJ Dillashaw, of Yorba Linda, Calif., has accepted a two-year sanction for a violation of the UFC Anti-Doping Policy after testing positive for a prohibited substance.
Dillashaw, 33, tested positive for recombinant human erythropoietin (rHuEPO) as the result of an in-competition urine sample he provided on January 18, 2019. rHuEPO is a synthetic hormone used to stimulate the body’s production of red blood cells, thereby increasing oxygen transport and aerobic power, and is a prohibited substance in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
“We all know the pressures to win at all levels of all sport are real and intense,” said USADA CEO Travis T. Tygart. “It is exactly why strong anti-doping efforts are necessary to protect clean athletes’ rights, health, and safety, and to ensure that those who do succumb to these pressures and decide to break the rules will be held accountable in a real and meaningful way, as in this case.”
Dillashaw’s two-year period of ineligibility, the standard sanction for a non-Specified Substance under the UFC Anti-Doping Policy, began on January 18, 2019, the date his sample was collected.
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (UFC.USADA.org) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (UFC.GlobalDRO.com), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts. Many of the resources available to athletes are provided in multiple languages, including Russian, Spanish, French, Portuguese, Korean, and Japanese.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean @usada.org, by phone at 1 877-Play Clean (1-877-752-9253), or by mail.
Since the suspension is retroactive to the date of the drug test failure, it would mean that Dillashaw is able to return to action on January 18 of 2021.
